Provided by Tiger Trade Technology Pte. Ltd.

INVESCO BIOTECHNOLOGY & GENOME ETF

98.68
+1.741.79%
Post-market: 98.62-0.0592-0.06%19:30 EDT
Volume:128.25K
Turnover:12.62M
Market Cap:406.56M
PE:55.03
High:98.68
Open:97.34
Low:97.30
Close:96.94
52wk High:98.82
52wk Low:67.69
Shares:4.12M
Float Shares:4.12M
Volume Ratio:6.45
T/O Rate:3.11%
Dividend:1.55
Dividend Rate:1.57%
EPS(TTM):1.79
EPS(LYR):18.65
ROE:24.76%
ROA:0.08%
PB:1.64
PE(LYR):5.29

Loading ...

Teva's Stock Jumps over 3% as Immune Disorder Drug Meets Main Goal in Mid-Stage Trial

Reuters
·
Yesterday

Biogen : Piper Sandler Raises Target Price to $245 from $225

THOMSON REUTERS
·
1 hour ago

Vertex Minerals Seeks Trading Halt Ahead of Capital Raising Plan

TIPRANKS
·
5 hours ago

Biogen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
7 hours ago

Amgen to Present at Wells Fargo Healthcare Conference Webcast

Reuters
·
8 hours ago

NASDAQ Top and Bottom Performing Stocks at About 02:45 P.m. EDT on 2026-09-02

Reuters
·
10 hours ago

Alnylam Pharmaceuticals Inc Stock (ALNY) Moved Up by 7.90% on Sep 2: Facts Behind the Movement

TradingKey
·
12 hours ago

Political and General News Events from September 2

Reuters
·
Yesterday

Alnylam to Webcast Investor Conference Presentations in September

Reuters
·
Yesterday

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Alumis Inc. (ALMS) and Medtronic (MDT)

TIPRANKS
·
Yesterday

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Yesterday

What Does Crinetics Pharmaceuticals (CRNX) Delisting Mean After The Takeover Closed?

Simply Wall St.
·
Yesterday

FedEx Incheon Gateway Wins IATA CEIV Pharma Certification

Reuters
·
Yesterday

Investors Shrug Off Good News for Heart Patients from New Meds

Dow Jones
·
Yesterday

Vertex Pharmaceuticals Closes Crinetics Pharmaceuticals Acquisition

MT Newswires Live
·
Sep 01

Vertex Pharmaceuticals completes acquisition of Crinetics Pharmaceuticals

TIPRANKS
·
Sep 01

Vertex Names Jonathan Poole CFO Effective Jan. 1, 2027

Reuters
·
Sep 01

Vertex Completes Acquisition of Crinetics Pharmaceuticals and Announces Expansion of Executive Leadership Team

THOMSON REUTERS
·
Sep 01

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

Reuters
·
Sep 01

Stoke Therapeutics and Biogen Announce Presentations of Clinical Data from Studies of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16TH European Epilepsy Congress (Eec)

THOMSON REUTERS
·
Sep 01